Clinical Trial Update: Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating lenalidomide in combination with azacitidine for advanced myelodysplastic syndromes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Mikkael Sekeres MD | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-19